Skip to main content

Table 3 Patterns of reverse transcriptase drug resistance mutations among women with detectable resistance at 12 months postpartum

From: Virologic and immunologic failure, drug resistance and mortality during the first 24 months postpartum among HIV-infected women initiated on antiretroviral therapy for life in the Mitra plus Study, Dar es Salaam, Tanzania

Serial Number

Subtype

NRTI

NNRTI

1

U*

-

K103KN

2

C

-

K103KN, H221HY

3

A1

-

K103KN**

4

A1

M184V

KV106A, Y188CWY

5

C

-

V106A

6

A1

M184V

Y181C, H221HY

7

U

M184V

K101N, Y181C,H221HY

8

A1

M184IM

-

9

AI

 

Y181C

10

C

M184V

Y181C

11

D

-

Y181CY, Y188CY

12

U

-

K101Q, E138EGKR

13

A1

-

K103N, V108IV

14

CRF10_CD

M184V

K103N

15

CRF10_CD

M184V

K103N, M230L

16

U

M184V

V106AV, G190AG

17

C

M184V

K101EK, G190A

18

A1

M184V

-

19

U

M184IMV

K103KN, Y181CY

20

A1

M184V

Y181CY, H221HY

  1. *U = unclassified.
  2. ** = Minor viral population with resistance associated mutation.